{"title":"Deep Ensemble Learning for Multiclass Skin Lesion Classification.","authors":"Tsu-Man Chiu, I-Chun Chi, Yun-Chang Li, Ming-Hseng Tseng","doi":"10.3390/bioengineering12090934","DOIUrl":null,"url":null,"abstract":"<p><p>The skin, the largest organ of the body, acts as a protective shield against external stimuli. Skin lesions, which can be the result of inflammation, infection, tumors, or autoimmune conditions, can appear as rashes, spots, lumps, or scales, or remain asymptomatic until they become severe. Conventional diagnostic approaches such as visual inspection and palpation often lack accuracy. Artificial intelligence (AI) improves diagnostic precision by analyzing large volumes of skin images to detect subtle patterns that clinicians may not recognize. This study presents a multiclass skin lesion diagnostic model developed using the CSMUH dataset, which focuses on the Eastern population. The dataset was categorized into seven disease classes for model training. A total of 25 pre-trained models, including convolutional neural networks (CNNs) and vision transformers (ViTs), were fine-tuned. The top three models were combined into an ensemble using the hard and soft voting methods. To ensure reliability, the model was tested through five randomized experiments and validated using the holdout technique. The proposed ensemble model, Swin-ViT-EfficientNetB4, achieved the highest test accuracy of 98.5%, demonstrating strong potential for accurate and early skin lesion diagnosis.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 9","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467972/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12090934","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The skin, the largest organ of the body, acts as a protective shield against external stimuli. Skin lesions, which can be the result of inflammation, infection, tumors, or autoimmune conditions, can appear as rashes, spots, lumps, or scales, or remain asymptomatic until they become severe. Conventional diagnostic approaches such as visual inspection and palpation often lack accuracy. Artificial intelligence (AI) improves diagnostic precision by analyzing large volumes of skin images to detect subtle patterns that clinicians may not recognize. This study presents a multiclass skin lesion diagnostic model developed using the CSMUH dataset, which focuses on the Eastern population. The dataset was categorized into seven disease classes for model training. A total of 25 pre-trained models, including convolutional neural networks (CNNs) and vision transformers (ViTs), were fine-tuned. The top three models were combined into an ensemble using the hard and soft voting methods. To ensure reliability, the model was tested through five randomized experiments and validated using the holdout technique. The proposed ensemble model, Swin-ViT-EfficientNetB4, achieved the highest test accuracy of 98.5%, demonstrating strong potential for accurate and early skin lesion diagnosis.
皮肤是人体最大的器官,起着抵御外界刺激的保护作用。皮肤损伤可能是炎症、感染、肿瘤或自身免疫性疾病的结果,可能表现为皮疹、斑点、肿块或鳞片,或者在变得严重之前保持无症状。传统的诊断方法如目视检查和触诊往往缺乏准确性。人工智能(AI)通过分析大量皮肤图像来检测临床医生可能无法识别的细微模式,从而提高诊断精度。本研究提出了一个使用CSMUH数据集开发的多类别皮肤病变诊断模型,该模型主要针对东部人群。该数据集被分为七个疾病类别进行模型训练。共对包括卷积神经网络(cnn)和视觉变压器(ViTs)在内的25个预训练模型进行了微调。采用硬投票和软投票的方法,将前三名模型组合成一个整体。为了保证模型的可靠性,通过5个随机实验对模型进行了检验,并使用holdout技术对模型进行了验证。所提出的集成模型swwin - viti - efficientnetb4达到了98.5%的最高测试准确率,显示出准确和早期皮肤病变诊断的强大潜力。
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering